ResourceClinical Diagnostics
Enhance your gestational diabetes workflow with HemoCue
24 Jun 2025Learn how the HemoCue® Glucose 201 System streamlines gestational diabetes screening with fast, in-office results. This CLIA-waived solution supports both prenatal and postpartum oral glucose tolerance testing (OGTT), enhancing patient care while eliminating long lab wait times.
Related products
Request Quote for All Products
HemoCue® Glucose 201 System
HemoCueProviding lab accuracy and ease of use, the HemoCue 201 System has become a standard in Glucose point-of-care testing. Allows you to accurately measure blood glucose levels to aid in the diagnosis and monitoring of diabetes.
Links
Tags
DiabetesDiabetes is a metabolic disorder characterized by high blood sugar levels, either due to insufficient insulin production or resistance to its effects. Ongoing diabetes innovation focuses on developing better diagnostic tools, treatments, and preventive measures. Browse our peer-reviewed product directory to find the best diabetes diagnostic tools, compare products, check reviews, and get pricing directly from manufacturers.Prenatal TestingWomens HealthPregnancy TestingPoint of Care SolutionsPoint of care solutions provide medical diagnostics and treatments at or near the site of patient care. These technologies offer rapid results, helping healthcare providers make quick decisions. From glucose monitors to molecular diagnostics, point of care solutions are transforming healthcare delivery by reducing wait times and improving patient outcomes. Explore the best point of care products in our peer-reviewed product directory, compare options, check reviews, and get pricing directly from manufacturers.